Better Health for All

The company's core product, the PreTRM® Test, predicts the risk of spontaneous preterm delivery.

The AVERT Trial demonstrated an 18% reduction in severe neonatal morbidity and mortality. The company's entire business is focused on improving maternal and neonatal health through these biomarker-based tests, indicating that 100% of its product portfolio delivers exceptional health benefits.

Fair Pay & Worker Respect

Sera Prognostics offers competitive health, dental, and vision plans, 401k matching, stock options, 14 paid holidays, 3 weeks of vacation time, and flexible remote work.

The company has a Corporate Code of Conduct and Ethics and Whistleblower Policy, effective July 14, 2021, which applies to all employees and directors. This policy includes an anti-retaliation pledge for good-faith reporting and an anonymous 24/7 whistleblower hotline. Employment decisions are made without regard to protected status, and the company is committed to a work environment free of sexual harassment. Employee reviews on Glassdoor indicate a 4.5 out of 5-star rating based on 17 reviews, with 96% of employees recommending the company to a friend, and 100% CEO approval. On Indeed, the company has an overall rating of 4.6 out of 5 stars based on 5 reviews, with pay and benefits rated 3.8 out of 5 stars.

Fair Trade & Ethical Sourcing

No specific, concrete evidence was found in the provided articles to assess Sera Prognostics, Inc. against any of the KPIs for Fair Trade & Ethical Sourcing. The articles primarily consist of a terms and conditions agreement

and a code of conduct , neither of which contain explicit data points regarding fair-trade certifications , supplier audit frequency , forced or child labor incidents , supply chain traceability , remediation speed for supplier violations , ethical clauses in supplier contracts , spend on high-risk materials , or supplier diversity spend . Information about internal compliance audits or general fair dealing with suppliers in the company's code of conduct does not directly address the specific requirements of the KPIs related to supplier contracts or external audits.

Honest & Fair Business

Sera Prognostics has a formal whistleblower protection policy that includes an anonymous hotline and emphasizes confidentiality and non-retaliation.

The company also has outlined anti-corruption and anti-bribery policies, and its Audit Committee Charter mentions compliance with relevant laws and regulations, including anti-corruption.

Kind to Animals

Sera Prognostics, Inc. is listed by CrueltyFreeInvesting.org as engaging in "No Animal Exploitation."

This indicates a comprehensive policy against animal testing and other forms of animal exploitation.

No War, No Weapons

Sera Prognostics, Inc. is consistently described as a health diagnostics company focused on improving maternal and neonatal health. Its core business activities, R&D, and use of proceeds are entirely related to healthcare, such as expanding commercial infrastructure in the US and EU, and funding studies for its PreTRM test.

There is no evidence of any revenue from arms or defense contracts, investment in dual-use technologies, sales to embargoed regimes, or involvement in military, intelligence, or surveillance activities. The company's Code of Conduct prohibits company funds, property, or services from being contributed to any political party, committee, or candidate, but does not specify lobbying on arms control. No information is available regarding conflict minerals, human rights due diligence in conflict areas, or specific ethical red lines related to weapons, as these are not applicable to its stated business model.

Planet-Friendly Business

The provided articles do not contain specific, quantitative data points for any of the Planet-Friendly Business KPIs. While the company is certified with DIN EN ISO 14001:2015 for environmental management and signed the UN Global Compact in 2022, these are general commitments and certifications, not direct metrics for the defined KPIs.

There is a stated aim to reduce CO2 emissions to a minimum by 2030, but this is a forward-looking goal without specific current emission levels or validated science-based targets. Information about a photovoltaic system covering one plant's electricity demand and a 30% reduction in gas consumption are specific to certain aspects or facilities, but not company-wide metrics that map to the provided KPIs. Similarly, mentions of converting the vehicle fleet to alternative drives (40% of the fleet) or switching to recycled packaging materials are either not directly covered by a KPI or are forward-looking statements without quantifiable outcomes against the rubric's thresholds. No data is available for total emissions, renewable energy percentage, water use per revenue, waste diversion rates, or any other specific environmental performance metrics required by the rubric.

Respect for Cultures & Communities

The provided articles, including financial reports and company news, do not contain any specific, concrete data points related to Sera Prognostics's engagement with cultures and communities. There is no information on formal partnerships, reinvestment in local development, cultural appropriation incidents, impact assessment protocols, local employment, grievance mechanisms, FPIC participation, community governance, cultural preservation investments, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving to cultural organizations, community fund allocation, language inclusivity, cultural incident response, or cultural sensitivity training completion.

All relevant KPIs lack explicit evidence.

Safe & Smart Tech

The company states there have been no breaches, violations, outages, or unauthorized uses of or accesses to personal data, and no written communications alleging a breach.

It maintains a comprehensive cybersecurity program with preventative measures. The company uses machine learning and artificial intelligence in bioinformatics analysis and adheres to authoritative guidelines published by NAM for developing and validating omics predictions. It is CLIA certified, CAP accredited, and NYS approved. Sera provides regular, mandatory training for employees and contractors regarding cybersecurity threats and conducts regular phishing email simulations. The company uses Secure Socket Layer (SSL) technology to protect information with server authentication and data encryption. It represents that there have been no incidents of unauthorized data use. HIPAA privacy regulations grant patients the right to access their medical records. The company monitors, identifies, prevents, and mitigates cybersecurity threats, employing tools like third-party real-time risk assessments, data loss prevention, and continuous monitoring. HIPAA limits most disclosures of health information to the minimum amount necessary. The company is subject to and represents compliance with HIPAA, HITECH, CLIA, FDA regulations, and various state laws, and undergoes regular inspections.

Zero Waste & Sustainable Products

The company's clinical laboratory operations are subject to numerous federal, state, and local environmental, health, and safety laws and regulations concerning the handling and disposal of hazardous and medical waste.

The laboratory is CLIA certified, CAP accredited, and requires approval by the Utah Department of Health to operate, indicating compliance with industry standards for hazardous waste management.